Real-World Data Back Avelumab in Merkel Cell Carcinoma
Avelumab demonstrates effectiveness against Merkel cell carcinoma in a real-world population, Medscape reports, extending evidence for the PD-L1 inhibitor beyond controlled trials.
Topic
Topic
Avelumab demonstrates effectiveness against Merkel cell carcinoma in a real-world population, Medscape reports, extending evidence for the PD-L1 inhibitor beyond controlled trials.